Metabolic syndrome and serum carotenoids: Findings of a cross-sectional study in Queensland, Australia by Coyne, Terry et al.
 QUT Digital Repository:  
http://eprints.qut.edu.au/29553
Coyne, Terry and Ibiebele, Torukiri and Baade, Peter and McClintock, Christine and 
Shaw, Jonathan (2009) Metabolic syndrome and serum carotenoids : findings of a 
cross-sectional study in Queensland, Australia. The British Journal of Nutrition: 
An International Journal of Nutritional Science, 102(11). pp. 1668-1677.
 
 © Copyright 2009 [please consult the authors].
 
 1
Article Title: 1 
Metabolic syndrome and serum carotenoids: findings of a cross-sectional study in Queensland, 2 
Australia 3 
 4 
Short running title 5 
Metabolic syndrome and serum carotenoids 6 
 7 
Authors: 8 
Terry Coyne1*, Torukiri I Ibiebele2, Peter D Baade3, Christine S. McClintock4 and Jonathan E 9 
Shaw5 10 
Affiliations of each author: 11 
1 School of Population Health, University of Queensland, Brisbane, Australia 12 
2 Queensland Institute of Medical Research, Brisbane, Australia 13 
3 Viertel Center for Research in Cancer Control, Cancer Council Queensland, and School of 14 
Public Health, Queensland University of Technology, Brisbane, Australia  15 
4 Center for Military & Veterans’ Health, University of Queensland, Brisbane, Australia 16 
5  Baker IDI Heart and Diabetes Institute, Melbourne, Australia 17 
 18 
* Corresponding author:  Dr Terry Coyne, Senior Lecturer (retired) School of Population Health, 19 
The University of Queensland. P.O. Box 112, Laughlintown PA 15655 USA.  Telephone: +1 20 
(724) 238 2288, Fax: +1 412 242 2840,  email:  terrycoyne@comcast.net 21 
Keywords: 22 
Carotenoids:  Metabolic syndrome:  Cross-sectional studies  23 
 24 
Several components of the metabolic syndrome, particularly diabetes and cardiovascular disease, 25 
are known to be oxidative stress-related conditions and there is research to suggest that 26 
antioxidant nutrients may play a protective role in these conditions. Carotenoids are compounds 27 
derived primarily from plants and several have been shown to be potent antioxidant nutrients. 28 
The aim of this study was to examine the associations between metabolic syndrome status and 29 
major serum carotenoids in adult Australians.  Data on the presence of the metabolic syndrome, 30 
based on International Diabetes Federation 2005 criteria, were collected from 1523 adults aged 31 
25 years and over in six randomly selected urban centers in Queensland, Australia, using a cross-32 
sectional study design.  Weight, height, BMI, waist circumference, blood pressure, fasting and 2-33 
hour blood glucose and lipids were determined, as well as five serum carotenoids.  Mean serum 34 
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alpha-carotene, beta-carotene and the sum of the five carotenoid concentrations were 35 
significantly lower (p<0.05) in persons with the metabolic syndrome (after adjusting for age, 36 
sex, education, BMI status, alcohol intake, smoking, physical activity status and vitamin/mineral 37 
use) than persons without the syndrome.  Alpha, beta and total carotenoids also decreased 38 
significantly (p<0.05) with increased number of components of the metabolic syndrome, after 39 
adjusting for these confounders. These differences were significant among former smokers and 40 
non-smokers, but not in current smokers. Low concentrations of serum alpha-carotene, beta-41 
carotene and the sum of five carotenoids appear to be associated with metabolic syndrome status. 42 
Additional research, particularly longitudinal studies, may help to determine if these associations 43 
are causally related to the metabolic syndrome, or are a result of the pathologies of the 44 
syndrome. 45 
 46 
Introduction 47 
Although there is no universal definition of the metabolic syndrome, it is generally 48 
described as a constellation of pathologies or anthropometric conditions, which include central 49 
obesity, glucose intolerance, lipid abnormalities, and hypertension.  It is, however, universally 50 
accepted that the presence of the metabolic syndrome is associated with increased risk of type 2 51 
diabetes and cardiovascular disease (1, 2).  52 
The prevalence of the metabolic syndrome in developed countries varies widely 53 
depending upon definitions used and age ranges included, but is estimated to be 24% among 54 
adults 20 years and over in the US (3).  Given the impending worldwide epidemic of obesity, 55 
diabetes and cardiovascular disease, strategies aimed at greater understanding of the pathology 56 
of the syndrome, as well as strategies aimed at preventing or treating persons with the syndrome 57 
are urgently required.  58 
Both diabetes and cardiovascular disease are known to be oxidative stress-related 59 
conditions and some researchers (4) suggest that antioxidant nutrients may play a protective role 60 
in these conditions.  Several cross–sectional surveys (5-7) have found lower levels of serum 61 
carotenoids among those with impaired glucose metabolism or type 2 diabetes.  Carotenoids are 62 
compounds derived primarily from plants and several have been shown to be potent antioxidants 63 
(8).  There is considerable epidemiological evidence that some serum carotenoids may play a 64 
protective role against the development of chronic diseases such as atherosclerosis (9, 10), stroke 65 
(11), hypertension (12), certain cancers (10, 13), inflammatory diseases (14) and diabetic retinopathy 66 
(15).  The primary carotenoids found in human serum are alpha ()-carotene, beta ()-carotene, 67 
beta ()-cryptoxanthin, lutein/zeaxanthin and lycopene (16) 68 
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Several studies have found an association between fruit and vegetable intake, or dietary 69 
patterns rich in fruit and vegetables, with a lower risk of the metabolic syndrome. (17-20).  Other 70 
studies, however, have failed to find such associations (21)  Results of clinical trials testing 71 
supplements of these nutrients with chronic diseases, however, have not been promising (22).   72 
Few studies have investigated associations of antioxidant nutrients and the metabolic 73 
syndrome.  Ford and colleagues (23) reported lower levels of several carotenoids and vitamins C 74 
and E among those with metabolic syndrome present compared with those without the syndrome 75 
in the Third National Health and Nutrition Examination Survey.  Sugiura et al (24) suggested that 76 
several carotenoids may exert a protective effect against the development of the metabolic 77 
syndrome, especially among current smokers. Confirming these findings in another population 78 
may add strength to these associations.   79 
In this study, we investigated the relationships between these five primary serum 80 
carotenoids and the metabolic syndrome in a cross-sectional population-based study in 81 
Queensland, Australia. 82 
 83 
Subjects and Methods  84 
Subjects 85 
The study was conducted in Queensland, Australia between October and December 2000 86 
as part of a national study, the Australian Diabetes, Obesity and Lifestyle Study (AusDiab), to 87 
determine the prevalence of diabetes and associated cardiovascular risk factors among adults 88 
aged 25 years and over.  Details of the sampling framework, overall study design, methods and 89 
central findings have been published elsewhere (25, 26).  The study was approved by the 90 
International Diabetes Institute and The University of Queensland ethics committees.  Six urban 91 
sites were randomly selected from census collector districts (CDs) in Queensland. The CDs were 92 
selected without replacement and with probability proportional to size.  Non-institutionalised 93 
adults aged 25 years and over residing in private dwellings were included in the survey if they 94 
had resided permanently at the address for a minimum of 6 months prior to the survey.  Persons 95 
with physical or intellectual disabilities that precluded participation in the study were not 96 
included.  97 
Trained interviewers conducted house-to-house interviews and eligible participants were 98 
invited to attend a biomedical examination which included collection of blood samples, blood 99 
pressure determinations, anthropometric measurements and the administration of standardised 100 
questionnaires related to diet as well as socio-demographic, lifestyle and health related 101 
characteristics.  All respondents gave informed consent to participate in the survey upon arrival 102 
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at the testing site.  A total of 1536 persons (890 females and 646 males) in Queensland 103 
completed the physical examination.  Although the overall response rate in the study was low 104 
(70% of eligible adults took part in the initial household survey, and of those, 55% completed 105 
the physical examination), the internal validity and quality control of the data collection were of 106 
high quality (26).  107 
 108 
Methods 109 
Study participants arrived for the examination having fasted for at least 12 hours.  Blood 110 
pressure measurements were taken using Dinamap sphygmomanometer.  Blood was drawn for 111 
fasting glucose.  Participants not taking hypoglycaemic medication completed an oral glucose 112 
tolerance test (OGTT) (two hours after consuming a 75-gram glucose drink).  Fasting and two-113 
hour (2h) plasma glucose were measured enzymatically (glucose oxidase) on an Olympus 114 
AU600 analyser.  Participants were also classified as having diabetes if they were receiving 115 
treatment for diabetes in the form of tablets or insulin at the time of the study. 116 
Lipids; total cholesterol (chol), high-density lipoprotein cholesterol (HDL), and 117 
triglyceride were measured enzymatically on an Olympus AU 600.  Low density lipoprotein 118 
(LDL) cholesterol was calculated from the equation of Friedwald et al (27):  LDL=total 119 
cholesterol-[HDL+ (triglyceride/5)]   120 
Blood was drawn for the carotenoid determinations at the time of the 2h OGTT, or 2 121 
hours after the fasting sample for those who did not have the OGTT.  Serum samples were 122 
meticulously handled and protected from light at each stage of processing to prevent 123 
deterioration and degradation.  The serum was pipetted, frozen, packed in dry ice and shipped to 124 
the laboratory in Brisbane and were analyzed within three weeks of collection.  The five serum 125 
carotenoids were assayed simultaneously according to the high performance liquid 126 
chromatography (HPLC) procedure described by Talwar et al. (28).  The intrabatch coefficient of 127 
variations by this method were 6.5%, 7.6%, 7.3% 6.9% and 9.0% for -carotene, -carotene, -128 
cryptoxanthin, lutein and lycopene respectively and the interbatch (analyzed after stored at -70 C 129 
over a period of 8 weeks) CVs were 13%, 9.6%, 8.7%, 8.5 and 11% respectively.  130 
The diagnostic criteria for the metabolic syndrome are based on the 2005 International 131 
Diabetes Federation (IDF) definition (29).  According to the IDF, to be identified as having the 132 
metabolic syndrome a person must have central obesity (defined as waist circumference ≥94 cm 133 
for Europid men and ≥80 cm for Europid women, with ethnicity specific values for other groups) 134 
plus any two of the following four factors: raised serum triglyceride level (≥1.7 mmol/L), 135 
reduced serum HDL cholesterol (<1.03 mmol/L in males and <1.29 mmol/L in females – or 136 
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specific treatment for these lipid abnormalities), raised blood pressure (systolic blood pressure 137 
≥130 mmHg or diastolic ≥85 mmHg - or treatment of previously diagnosed hypertension, 138 
impaired fasting glycemia (fasting plasma glucose ≥5.6 mmol/L or previous diagnosed type 2 139 
diabetes). 140 
Of those diagnosed with diabetes, 2.5% were classified as having type 1 diabetes and 141 
were excluded from the analysis because they do not share common aetiological factors such as 142 
obesity, increasing age, nutrition or physical activity with metabolic syndrome.  Participants 143 
were defined as having Type 1 diabetes if insulin treatment had been started within 2 years of 144 
diagnosis and, if they were 40 years of age or older when diagnosed, their current BMI was < 27.   145 
Demographic and lifestyle variables were collected using standardised questionnaires. 146 
Height and weight were measured by trained personnel and body mass index (BMI) calculated 147 
as weight (in kilograms)/height (in meters squared).  BMI was categorised as: obese (BMI 30), 148 
overweight (BMI 25 to <30) and normal weight (BMI <25).  As there were only 18 participants 149 
classified as underweight (BMI<18.5), they were grouped with the normal weight group.  150 
Waist circumference was measured half-way between the lower border of the ribs and the 151 
iliac crest on a horizontal plane.  Using a steel measuring tape, two measurements were 152 
recorded.  If the measurements varied by more than 2 cm, a third measurement was taken.   The 153 
mean of the two closest measurements was calculated.  154 
Blood pressure measurement was performed in a seated position after participants had 155 
rested for at least 5 minutes, using a Dinamap semiautomatic oscillometric recorder. An 156 
appropriate cuff size was used and the arm was supported by a table at heart level. Three 157 
readings were taken at 1-minute intervals. The mean of the first two readings was recorded. If 158 
the difference between the three readings was greater than 10mmHg, the mean of the two closest 159 
measurements was used.  160 
Physical activity beneficial to health was categorised as: sufficiently active (greater than 161 
150 minutes “physical activity time” in the previous week), insufficiently active but not 162 
sedentary (less than 150 minutes “physical activity time” in the previous week), and sedentary 163 
(no participation in physical activity in the previous week).  “Physical activity time” was 164 
calculated as the sum of the time spent walking, or performing moderate activity plus double the 165 
time spent in vigorous activity to reflect its greater intensity.  166 
Vitamin supplement use during the previous 24 hours was categorised as yes for 167 
respondents who indicated that they took any vitamin or mineral supplements on the previous 168 
day and no for respondents who indicated they did not. 169 
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Criteria used to assess the number of metabolic syndrome components present in a 170 
participant using the 2005 International Diabetes Federation (29) definition are as follows: 171 
Components = 0 -none of the metabolic syndrome components (i.e. abdominal obesity, raised 172 
triglyceride, reduced HDL-cholesterol, raised blood pressure, and impaired fasting plasma 173 
glucose) are present; Components = any 1 one of the five metabolic syndrome components is 174 
present ; Components = 2 - any two of the five components are present;  Components = 3 any 175 
three of the components are present; Components = 4 - any four of the components are present;  176 
Components = 5 = all five metabolic syndrome components are present.  177 
Participants were asked, “How many serves of vegetables do you usually eat each day?  178 
Including fresh, frozen or tinned vegetables (A serve = ½ cup cooked vegetables or 1 cup of 179 
salad vegetables).”  Usual consumption of fruit was assessed by the question, “How many serves 180 
of fruit do you usually eat each day?  Including fresh, frozen or tinned fruit (A serve = 1 medium 181 
piece or 2 small pieces of fruit or 1 cup of diced pieces of fruit.).”  Participants were categorised 182 
into three groups according to their responses to both questions;  1 serve, 2-3 serves, 4 serves.  183 
 184 
Statistical analyses   185 
Data were analysed using the survey (svy) commands in STATA statistical software 186 
version 8 (30).  These commands take into account the complex cluster survey design in the 187 
calculation of estimates, variance, standard errors and confidence intervals. Age-adjusted means 188 
or percentages for selected baseline characteristics were weighted for age and sex to the 189 
Queensland population aged over 25 for the survey year. 190 
Pearson’s chi-square statistic was used to assess the relationship between presence or 191 
absence of the metabolic syndrome and selected categorical variables.  Student’s t-test was used 192 
to compare differences in means between two groups; analysis of variance was used to assess 193 
overall differences in means between serum carotenoids and variables with more than two 194 
groups. 195 
Distributions of serum carotenoids were skewed and therefore natural logarithmically 196 
transformed to better approximate the normal distribution for regression analyses.  Association 197 
between log transformed serum carotenoids as dependent variables and metabolic syndrome 198 
status were assessed using multiple linear regression analysis.  Results are reported as back-199 
transformed geometric means.  Analysis was performed for each serum carotenoid separately, 200 
and the sum of the five carotenoids, adjusting for the following potential confounders: age, sex, 201 
education, BMI, smoking, alcohol intake, physical activity, and vitamin use.  We further 202 
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performed stratified analysis by smoking status to further investigate if the association between 203 
serum carotenoids and metabolic syndrome is modified by smoking status.   204 
The confounders were included simultaneously into the model.  Due to missing values, 205 
the sample size is not the same for all analyses. 206 
 207 
Results  208 
The prevalence of the metabolic syndrome by demographic and health-related 209 
characteristics is provided in Table 1.  The overall prevalence of the syndrome was 24% and was 210 
significantly higher among males than females.  As would be expected, significant differences in 211 
prevalence of the syndrome were seen with body mass index, waist circumference, systolic and 212 
diastolic blood pressure and blood lipids.  Significant differences were also evident by age 213 
group, smoking status, educational status and income. Income was marginally inversely 214 
associated. The prevalence increased with age, and was lower in those with post graduate 215 
education. No significant differences were seen by alcohol intake, physical activity levels, 216 
vitamin usage, or fruit intake.  There was actually an inverse relationship between vegetable 217 
intake (not fruit) and serum carotenoids.  Those who consumed 4 serves or more of vegetable 218 
were less likely to have the metabolic syndrome compared to those who consumed 1 serve or 219 
less of vegetables. 220 
 (Insert Table 1 about here) 221 
Table 2 provides the adjusted geometric mean of each of the serum carotenoids by 222 
metabolic syndrome status.  The mean concentrations of serum -carotene, -carotene and the 223 
sum of the five carotenoids were significantly lower for participants with the metabolic 224 
syndrome present compared with those without the syndrome, after adjusting for potential 225 
confounding variables including age, sex, educational status, BMI, smoking, alcohol intake, 226 
physical activity and vitamin use.   227 
(Insert Table 2 about here). 228 
Table 3 shows that concentrations of -carotene, -carotene and the sum of the five 229 
carotenoids decreased significantly as the number of components of the metabolic syndrome 230 
increased after adjusting for potential confounding variables as above..  Table 3 also indicates 231 
the percentage of participants with none, one, two, three, four or all five of the components. 232 
 (Insert Table 3 about here) 233 
Similarly there was an inverse association between quartiles of individual and total serum 234 
carotenoids and metabolic syndrome status and each of its components as shown in Table 4.  The 235 
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strength of these associations was strongest for -carotene, -carotene and the sum of the five 236 
carotenoids. 237 
(Insert Table 4 about here) 238 
Table 5 looks at the effect of smoking status on carotenoid concentrations and metabolic 239 
syndrome.  No significant differences in serum carotenoid concentrations by metabolic 240 
syndrome status were found among ‘current smokers’.  However, among ‘former’ and ‘never’ 241 
smokers serum -carotene and -carotene were significantly lower among those with metabolic 242 
syndrome than those without.  In addition, among ‘former’ smokers serum lycopene was 243 
marginally lower in those with metabolic syndrome, while among ‘never’ smokers total serum 244 
carotenoids was marginally lower in those with metabolic syndrome compared to those without. 245 
We also found no significant interaction between smoking status and serum carotenoid 246 
concentrations in relation to the metabolic syndrome status.  The following are the p values for 247 
interaction after adjustment for the confounding variables in relation to: α-carotene (p for 248 
interaction=0.25), β-carotene (p for interaction=0.15), β-cryptoxanthin (p for interaction=0.40), 249 
lutein/zeaxanthin (p for interaction=0.25), lycopene (p for interaction=0.41), and total serum 250 
carotenoid (p for interaction=0.15).   251 
(Insert Table 5 about here) 252 
Discussion   253 
This study was designed to investigate the association between several serum carotenoids 254 
and the metabolic syndrome.  The data from the present population study suggest that several 255 
serum carotenoids are inversely related to the metabolic syndrome.  Our study showed 256 
significantly lower concentrations of -carotene, -carotene and the sum of the five carotenoids 257 
among those with the metabolic syndrome present compared to those without.  We also found 258 
decreasing concentrations of all the carotenoids tested as the number of the metabolic syndrome 259 
components increased. This was significant for -carotene, -carotene, β-cryptoxanthin and total 260 
carotenoids.  These findings are consistent with data reported by Ford et al (23) from the third 261 
National Health and Nutrition Examination Survey (NHANES III).  In the NHANES III study, 262 
significantly lower concentrations of all the carotenoids, except lycopene, were found among 263 
persons with the metabolic syndrome compared with those without, after adjusting for 264 
confounding factors similar to those in our study.  The NHANES III study (19) also found 265 
decreasing concentrations of all the carotenoids (except lycopene) and total carotenoids with 266 
increasing number of metabolic syndrome components.  Our study used the criteria for 267 
metabolic syndrome as suggested by the International Diabetes Federation (31), which requires 268 
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central obesity as the major component.  In the NHANESIII study, central obesity is a 269 
component of the syndrome, but it is not a required component. Also we adjusted for BMI in all 270 
of our analyses, whereas the NHANES study did not.  This adjustment for BMI may have 271 
attenuated the strength of the association of several carotenoids in our study as compared with 272 
NHANES III. 273 
We did find that all the serum carotenoids decreased as BMI status increased and this 274 
was significant for all of the carotenoids.  This is consistent with findings of a prospective study 275 
by Anderson and colleagues (32) in which a high BMI status was strongly associated with lower 276 
concentrations of total carotenoids.  277 
Since serum carotenoids are considered reliable markers of vegetable and fruit intake, 278 
low serum concentrations could conceivably be due to lower intakes. Our previous study (33) did 279 
find statistically significant associations between vegetable and fruit intake and serum levels of 280 
-carotene, -carotene, -cryptoxanthin and lutein-zeaxanthin.  We also found fewer individuals 281 
with the highest vegetable intake with the metabolic syndrome compare with those with the 282 
lowest intakes of vegetables.  However, we found no association with intake of fruit and the 283 
syndrome. 284 
Several studies have investigated fruit and vegetable intake in relation to the metabolic 285 
syndrome with mixed results.  The NHANES study (19) reported significantly lower intakes of 286 
fruit and vegetables among those with the syndrome present compared to those without the 287 
syndrome.  To estimate the number of monthly servings of fruit and vegetables, they summed 21 288 
items on the NHANES food frequency questionnaire.  Esmaillzadeh (18) reported a significant 289 
inverse association between fruit and vegetable intake and the metabolic syndrome among 290 
Tehrani female teachers.  Fruit and vegetable intake was estimated from a semiquantitative food 291 
frequency questionnaire.  Several studies (17, 34) have suggested that a ‘healthy’ dietary pattern, or 292 
one of lower nutritional risk is associated with lower risk of the metabolic syndrome. Another 293 
study (21) of dietary patterns, however, showed no association with a ‘prudent’ dietary pattern, 294 
typified by a higher intake of vegetables, fruit, fish and poultry, and the metabolic syndrome, but 295 
did show a positive association with a ‘western’ pattern characterised by high intakes of refined 296 
grains, processed meat, fried foods and red meat. 297 
Although the assessment of fruit and vegetable intake in this study was relatively crude 298 
(i.e. how many serves of vegetables do you usually eat in a day?) and therefore may not 299 
accurately reflect true fruit and vegetable intake, our findings of vegetable intake does appear to 300 
be consistent with those of other studies suggesting a positive relationship between vegetable 301 
intake and the risk of the metabolic syndrome. Also our study was conducted from October 302 
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through December in Queensland, Australia.   These months are spring and early summer and as 303 
most of Queensland is tropical and subtropical the availability of fruit and vegetables is abundant 304 
year round.  Thus the time of year in which the study was conducted would have had little effect 305 
on results. 306 
Smokers have been found to have significantly lower serum carotenoid concentrations 307 
compared with non-smokers (35).  Overall, we found significantly lower concentrations of total 308 
carotenoids and the individual carotenoids, except lycopene, in smokers compared with non-309 
smokers (data not shown).  However, in relation to metabolic syndrome status, we found no 310 
significant difference in serum carotenoid levels by metabolic syndrome status among current 311 
smokers.  But among former and never smokers serum alpha-carotene and beta-carotene were 312 
relatively lower among those with metabolic syndrome than those without.  Serum lycopene was 313 
marginally lower for those with metabolic syndrome compared to those without among former 314 
smokers, while total serum carotenoids was marginally lower for those with metabolic syndrome 315 
compared to those without among never smokers.  We also found no significant interaction 316 
between smoking status and serum carotenoids in relation to the metabolic syndrome.   317 
Our findings were partly similar to that of Sugiura and co-workers (24)  who found inverse 318 
associations between serum β-carotene among non-smoking adults.  Our findings were also 319 
similar to those of Hozawa and co-investigators (36), how found an inverse association of total 320 
carotenoids with incidence of diabetes and several markers of glucose tolerance only among 321 
non- smokers, but no association among current smokers.  322 
There were several limitations in our study.  We did not have accurate data on the intake 323 
of any of these carotenoids from supplements.  Approximately a third of our participants 324 
reported taking a vitamin, mineral or herbal supplement in the 24 hours prior to the examination.  325 
Although we collected information about the supplements, there was no data base available that 326 
could estimate the content of these carotenoids in the supplement.  From investigation of a 327 
variety of supplements that were on the market at the time, few of them contained any of these 328 
carotenoids.  Approximately 57% of women in the study were post menopausal,and as might be 329 
expected,  had higher percentage of women with the syndrome.  We did not account for 330 
menopause status in our analyses,however,  331 
The cross-sectional design of our study does not permit us to draw inferences regarding 332 
causality.  It is not possible to conclude whether low serum concentrations of carotenoids found 333 
in participants with the metabolic syndrome in our study are the result of increased utilisation of 334 
these antioxidants due to the oxidative stress effects of the disease or whether the lower 335 
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concentrations are the result of lower intakes of dietary carotenoids and play a role in the 336 
pathogenesis of the syndrome.  337 
Oxidative stress is an imbalance, which produces free radicals that overwhelm the body’s 338 
antioxidant defences and high levels of oxidative stress are known to deplete the body’s reserves 339 
of antioxidants.  Oxidative stress has been implicated in the pathogenesis of several components 340 
of the metabolic syndrome including glucose or insulin abnormalities (4), hypertension (37) and 341 
obesity (38).  Recent studies (39) have reported elevated markers of oxidative stress among subjects 342 
with metabolic syndrome compared with those without the syndrome.  Thus the oxidative stress 343 
nature of the metabolic syndrome may cause greater utilisation of antioxidants resulting in lower 344 
concentrations of antioxidants such as carotenoids.  345 
Another hypothesis is that lower intakes of antioxidant-rich fruit and vegetables result in 346 
lower serum concentrations and thus are involved in the pathogenesis of these conditions.  347 
Epidemiologic studies have found lower antioxidant intakes with components of the metabolic 348 
syndrome such as diabetes status (40).  Suzuki and co-workers, (7) found a significantly lower 349 
odds ratio for high HbA1c among those with the highest intakes of carrots and pumpkin 350 
compared with a low intake group.  The large EPIC-Norfolk study found that persons with 351 
higher intakes of vegetables and fruit have higher serum carotenoid concentrations and lower 352 
risk of type 2 diabetes (41).  353 
While numerous observational studies have shown an inverse relationship between 354 
antioxidant intakes and serum concentrations and the risk of several of these components, 355 
clinical trials providing single or combination antioxidants as supplements have not resulted in 356 
any beneficial reduction in these conditions (22).  Further research, particularly longitudinal 357 
studies may shed light on whether low levels of carotenoids are causally involved in the 358 
development of the syndrome, or if they are a result of these pathologies. Clinical trials based on 359 
diets high in carotenoid-rich fruit and vegetables may also provide important insights not only in 360 
relation to the prevention of components of the metabolic syndrome, but also in reducing the risk 361 
of developing the syndrome itself. 362 
Obesity and the other components of the metabolic syndrome are increasing in most 363 
countries of the world today and will continue to increase.  As populations age, and as 364 
overweight and obesity continue to escalate, especially among children, these conditions will 365 
become an increasing burden on the health system.  Lifestyle interventions have been able to 366 
show dramatic reductions in risk of diabetes among those with IGT (42, 43).  However, strategies 367 
for both primary and secondary prevention will be necessary to reduce the burden of obesity, 368 
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diabetes and the metabolic syndrome in future years, in future generations in both developed and 369 
developing countries.   370 
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Table 1.  Age-adjusted means or percentages for selected baseline characteristics of AusDiab participants 518 
aged 25 years and over by metabolic syndrome status (N=15231) 519 
 Metabolic syndrome status  
Selected characteristics (%, mean) Present Absent P value2
 N Percent or Mean 
(SE)3 
n Percent or Mean 
(SE)3 
 
Gender (%)4 N Percent n Percent 0.05 
Male 195 26.7 451 73.3  
Female 229 21.3 661 78.7  
All persons 424 24.0 1112 76.0  
Age group (yrs) (%)4     <0.01 
25-34 19 11.0 161 89.0  
35-44 48 14.6 275 85.4  
45-54 114 29.4 270 70.6  
55-64 120 38.4 199 61.7  
65-74 88 38.0 145 62.0  
75+ 35 36.2 62 63.8  
Educational status (%)     0.04 
Secondary school or less 191 27.5 415 72.5  
Trade certificate, bachelor’s degree 214 23.0 598 77.0  
Post-graduate qualification 19 15.8 95 84.2  
Income (%)     0.06 
$800-1500+/week 136 19 465 81  
$400-799/week 133 24 327 76  
$0-399/week 147 30 299 70  
Body Mass Index (BMI) (%)     <0.01 
Obese (BMI>30) 208 57.2 149 42.8  
Overweight (BMI≥25 to <30) 189 28.3 379 71.7  
Normal (BMI<25) 27 3.2 584 96.8  
Smoking status (%)     0.05 
Current 59 25.1 147 74.9  
Former smokers 142 29.8 289 70.2  
Never smoked 218 20.8 660 79.2  
Alcohol intake (%)     0.12 
None 105 28.0 233 72.0  
≤ 60 std drinks/month 265 22.1 761 77.9  
> 60 std drinks/month 54 27.8 118 72.2  
Physical activity beneficial to health (%)     0.07 
Sufficiently active 179 22.0 542 78.0  
Insufficiently active 134 22.2 380 77.8  
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Sedentary 111 33.1 185 66.9  
Vitamin use (%)     0.81 
No 265 23.4 705 76.6  
Yes 116 22.8 340 77.2  
Fruit intake (serves/day) %     0.68 
≤ 1 serve 72 25.6 177 74.4  
1-3 serves 219 23.4 586 76.6  
≥ 4 serves 123 24.5 329 75.5  
Vegetable intake (serves/day) %     0.02  
≤ 1 serve 168 25.0 426 75.0  
1-3 serves 204 24.3 522 75.7  
≥ 4 serves 41 20.1 141 79.9  
Blood Pressure (mmHg)   Mean (SE)  Mean (SE)  
Systolic BP (mean, SE)  420 137.4 (1.9) 1104 121.6 (1.2) <0.01 
Diastolic BP (mean, SE)  421 73.4 (1.2) 1105 65.8 (1.1) <0.01 
Blood Lipids (mmol/L)      
HDL-cholesterol (mean, SE) 424 1.15 (0.03) 1112 1.46 (0.01) <0.01 
Triglyceride (mean, SE) 424 2.54 (0.14) 1112 1.13 (0.03) <0.01 
LDL-cholesterol (mean, SE) 377 3.70 (0.07) 1106 3.37 (0.04) 0.02 
Fasting plasma glucose (mmol/L, mean, 
SE) 
424 5.74 (0.08) 1112 5.10 (0.02) <0.01 
Waist circumference in (cm, mean, SE)      
Males 195 106.5 (0.91) 451 91.1 (1.09) <0.01 
Females 229 97.4 (1.42) 661 78.9 (1.33) <0.01 
1 N is not the same because of missing values 520 
2 Chi square statistic test of association with adjustment for cluster design; T-test for differences in means for 521 
variables with 2 groups 522 
3 Weighted for age and sex to the Queensland population aged over 25 for the survey year; 523 
   SE=Standard Error 524 
4 Unadjusted 525 
526 
  
20
 527 
Table 2.  Adjusted1 geometric mean concentrations of serum carotenoids by metabolic syndrome for adults 25 years 528 
and over who participated in the Queensland AusDiab study, 2000 (N=1523) 529 
 530 
Serum Carotenoid  
(mmol/L) 
Metabolic Syndrome present 
(n=420) 
Metabolic Syndrome absent 
 (n=1103) 
P value2 
 Mean3 95% CI Mean3 95% CI  
α-carotene  0.10 0.07-0.15 0.13 0.10-0.18 0.02 
β-carotene  0.45 0.33-0.62 0.59 0.47-0.73 0.01 
β -cryptoxanthin  0.20 0.16-0.24 0.21 0.18-0.25 0.19 
Lutein/zeaxanthin  0.41 0.36-0.46 0.41 0.34-0.50 0.89 
Lycopene  0.40 0.34-0.47 0.43 0.39-0.49 0.31 
Sum of serum carotenoids 1.82 1.62-2.04 2.02 1.76-2.33 0.04 
1 Multivariable linear regression model adjusting for potential cofounders including: age (25-34, 35-44, 45-54, 55-531 
64, 65-74, 75+); sex (male, female); education (post-graduate qualification, trade-certificate and bachelor degree, 532 
secondary school); BMI (obese, overweight, normal); alcohol intake (>60drinks per month, <60 drinks per month, 533 
none); smoking (current, former, never); physical activity (sedentary, insufficiently active, sufficiently active); and 534 
vitamin use during 24hrs (yes, no),  535 
 2 Serum carotenoids were log transformed for regression analyses.  Back transformed geometric mean reported in 536 
table.  537 
 538 
539 
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 540 
Table 3.  Mean (SE) age and sex adjusted1 concentrations of serum carotenoids by metabolic syndrome components 541 
among adults 25 years and over who participated in the Queensland AusDiab study, 2000 (N=1523) 542 
 Number of Metabolic Syndrome components2 present in participants  P
 0 
n=344 
1 
(n=367) 
2 
(n=344) 
3 
(n=250) 
4 
(n=155) 
5 
(n=63) 
Proportion of participants with metabolic 
syndrome components (%) 
22 24 23 17 10 4 
Serum Carotenoid4 (mmol/L) Mean (SE) 5 Mean (SE) Mean (SE) Mean (SE) Mean (SE) Mean (SE) 
α-carotene  0.21 (0.02) 0.18, (0.03) 0.17, (0.02) 0.15, (0.03) 0.12, (0.02) 0.10, (0.01) 0
β-carotene  0.83, (0.09) 0.73, (0.10) 0.68, (0.09) 0.60, (0.07) 0.48 (0.06) 0.48 (0.08) 0
β-cryptoxanthin  0.29, (0.03) 0.31, (0.04) 0.28, (0.02) 0.26, (0.03) 0.23, (0.02) 0.25, (0.06) 0
Lutein/zeaxanthin  0.46, (0.03) 0.44, (0.03) 0.46, (0.03) 0.43, (0.03) 0.46, (0.02) 0.38, (0.03) 0
Lycopene  0.62, (0.04) 0.60, (0.04) 0.56, (0.03) 0.49, (0.02) 0.48, (0.03) 0.38, (0.02) 0
Total serum carotenoids 2.42, 0.16 2.27, 0.21 2.14, 0.13 1.93, 0.15 1.78, 0.10 1.59, 0.16 0
1 Multivariable logistic regression model adjusted for age (25-34, 35-44, 45-54, 55-64, 65-74, 75+); sex (male, 543 
female); education (post-graduate qualification, trade-certificate and bachelor degree, secondary school); BMI 544 
(obese, overweight, normal); alcohol intake (>60drinks per month, <60 drinks per month, none); smoking (current, 545 
former, never); physical activity (sedentary, insufficiently active, sufficiently active); and vitamin use (yes, no). 546 
2 Components = 0 - none of the components of metabolic syndrome are present; 547 
2 Components =1 - any 1 of the metabolic syndrome components is present 548 
2 Components=2 - any 2 of the 5 metabolic syndrome components are present 549 
2 Components =3 - any 3 of the 5 metabolic syndrome components are present 550 
2 Components =4 - any 4 of the 5 metabolic syndrome components are present 551 
2 Components = 5 - all 5 metabolic syndrome components are present 552 
3 ANOVA used to test for differences in means for variables with more than 2 groups 553 
4 Serum carotenoids not log transformed. 554 
5 SE=Standard Error 555 
 556 
557 
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Table 4 (NEW). Odds Ratios (OR†) with 95% Confidence Intervals (CI) for Metabolic syndrome and its components according to quartiles of plasma serum 
carotenoids. 
 Metabolic syndrome 
(n=424) 
Abdominal obesity 
(n=858) 
High triacylglycerol 
(n=474) 
Low HDL cholesterol 
(n=4690 
High fasting blood 
glucose (n=297) 
High blood pressure 
(n=6670 
Serum carotenoids 
 
      
OR† 95% CI OR† 95% CI OR† 95% CI OR† 95% CI OR† 95% CI OR† 95% CI 
Alpha carotene (g/day) 
Q1  1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 
Q2  0.76 0.53, 1.08 0.74 0.37, 1.48 0.83 0.59, 1.18 0.65 0.37, 1.13 0.89 0.65, 1.21 0.81 0.57, 1.17 
Q3  0.59 0.40, 0.89 0.69 0.55, 0.87 0.53 0.36, 0.78 0.78 0.50, 1.19 0.72 0.47, 1.10 0.56 0.35, 0.91 
Q4  0.36 0.21, 0.63 0.47 0.33, 0.65 0.55 0.36, 0.83 0.46 0.24, 0.92 0.54 0.33, 0.90 0.50 0.42, 0.59 
P for trend = 0.005 = <0.01 = 0.011 = 0.06 = 0.011 = <0.01 
Beta-carotene 
Q1  1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 
Q2  0.63 0.51, 0.77 0.87 0.33, 2.27 0.70 0.37, 1.33 0.64 0.38, 1.06 0.94 0.47, 1.90 0.47 0.27, 0.80 
Q3  0.56 0.35, 0.89 0.58 0.24, 1.36 0.46 0.31, 0.69 0.60 0.31, 1.40 0.91 0.71-1.17 0.48 0.31, 0.73 
Q4  0.36 0.24, 0.55 0.57 0.31, 1.06 0.37 0.21, 0.64 0.39 0.20, 0.76 0.72 0.45, 1.17 0.35 0.23, 0.52 
P for trend =0.003 =0.03 = 0.004 = 0.03 = 0.11 = 0.002 
Beta-cryptoxanthin  
Q1  1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 
Q2  1.00 0.62, 1.63 0.77 0.43, 1.37 1.07 0.61-1.89 0.97 0.49, 1.91 1.07 0.75, 1.52 0.93 0.41, 2.09 
Q3  0.68 0.35, 1.32 0.82 0.29-2.29 0.59 0.46, 0.77 0.58 0.37, 0.90 1.09 0.33, 3.59 0.80 0.44, 1.46 
Q4  0.78 0.51, 1.20 0.88 0.47-1.64 0.71 0.46, 1.10 0.59  0.35, 1.01 0.69 0.40, 1.20 0.91 0.43, 1.94 
P for trend =0.07 =0.74 = 0.03 = 0.05 = 0.41 = 0.69 
Lutein/zeaxanthin  
Q1  1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 
Q2  1.13 0.55, 2.33 0.91 0.67, 1.25 1.00 0.53, 1.90 0.90 0.45, 1.80 0.95 0.75, 1.20 0.97 0.61, 1.55 
Q3  1.12 0.64, 1.95 1.17 0.72-1.91 1.37 0.85, 2.22 0.55 0.26, 1.18 1.09 0.64-1.88 0.88 0.55, 1.41 
Q4  0.93 0.56, 1.52 0.77 0.36, 1.67 1.19 0.57, 2.48 0.47 0.21, 1.05 0.57 0.33, 1.00 0.95 0.74, 1.23 
P for trend =0.79 =0.72 = 0.37 = 0.04 = 0.13 = 0.53 
Lycopene  
Q1  1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 
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Q2  0.98 0.54, 1.78 1.00 0.73-1.38 1.01 0.47, 2.19 0.93 0.59, 1.44 0.76 0.47, 1.24 1.32 0.96, 1.80 
Q3  0.72 0.44, 1.17 0.97 0.63, 1.48 0.76 0.48, 1.22 0.64 0.37, 1.09 0.88 0.54-1.42 1.09 0.80, 1.50 
Q4  0.76 0.48, 1.21 0.83 0.53, 1.29 0.75 0.47, 1.19 0.64 0.37, 1.11 1.13 0.86, 1.48 0.98 0.62, 1.57 
P for trend =0.14 = 0.29 =0.07 = 0.06 = 0.20 = 0.54 
Total serum carotenoids 
Q1  1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 1.00 Ref 
Q2  0.63 0.47, 0.85 0.66 0.45, 0.98 1.03 0.66, 1.61 0.63 0.33, 1.18 0.61 0.26, 1.43 0.62 0.35, 1.12 
Q3  0.87 0.51, 1.50 0.86 0.66, 1.12 0.88 0.68, 1.12 0.68 0.32, 1.41 0.98 0.73, 1.32 0.57 0.34, 0.94 
Q4  0.43 0.23, 0.79 0.60 0.35, 1.02 0.57 0.34, 0.96 0.41 0.20, 1.85 0.56 0.26, 1.22 0.47 0.27, 0.81 
P for trend =0.04 =0.10 = 0.03 = 0.05 = 0.14 = 0.008 
†OR = Odds Ratio 
Logistic regression adjusted for Adjusted for age (25-34, 35-44, 45-54, 55-64, 65-74, 75+); sex (male, female); education (post-graduate qualification, trade-certificate and bachelor degree, secondary school); alcohol intake (>60drinks per month, 
<60 drinks per month, none); smoking (current, former, never); physical activity (sedentary, insufficiently active, sufficiently active); vitamin use (yes, no) and BMI (obese, overweight, normal). 
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Table 5.  Relation between serum carotenoids and metabolic syndrome by smoking status 
 Current smokers (n=183) P value Former smokers (n=391) P value Never smokers (n=817)  
 Metabolic 
syndrome absent 
Metabolic 
syndrome 
present 
 Metabolic 
syndrome 
absent 
Metabolic 
syndrome 
present 
 Metabolic 
syndrome 
absent 
Metabolic 
syndrome 
present 
P value 
 Mean (95% CI) Mean (95% CI)  Mean (95% CI) Mean (95% CI)  Mean (95% CI) Mean (95% CI)  
Alpha carotene 0.08 (0.07-0.09) 0.07 (0.03-0.14) 0.59 0.14 (0.10-0.21) 0.11 (0.07-0.17) 0.03 0.15 (0.11-0.20) 0.11 (0.08-0.16) 0.04 
Beta-carotene 0.42 (0.36-0.50) 0.38 (0.19-0.76) 0.72 0.63 (0.47-0.84) 0.44 (0.29-68) 0.02 0.63 (0.51-0.78) 0.49 (0.37-0.64) 0.01 
Beta-cryptoxanthin 0.12 (0.10-0.15) 0.11 (0.09-0.15) 0.27 0.22 (0.19-0.25) 0.20 (0.15-0.28) 0.57 0.24 (0.20-0.28) 0.22 (0.18-0.27) 0.40 
Lutein/zeaxanthin 0.33 (0.28-0.40) 0.32 (0.29-0.36) 0.80 0.40 (0.34-0.48) 0.41 (0.34-0.48) 0.87 0.43 (0.35-0.53) 0.41 (0.35-0.48) 0.65 
Lycopene 0.37 (0.27-0.50) 0.39 (0.28-0.53) 0.80 0.48 (0.40-0.58) 0.37 (0.29-0.48) 0.06 0.43 (0.39-0.48) 0.43 (0.39-0.49) 0.97 
Total serum carotenoid 1.47 (1.29-1.67) 1.43 (1.02-2.00) 0.87 2.11 (1.79-2.50) 1.80 (1.45-2.24) 0.10 2.13 (1.85-2.47) 1.92 (1.77-2.10) 0.08 
Multivariable linear regression adjusting for age (25-34, 35-44, 45-54, 55-64, 65-74, 75+); sex (male, female); education (post-graduate qualification, trade-certificate and bachelor degree, secondary school); alcohol intake (>60drinks per month, 
<60 drinks per month, none); physical activity (sedentary, insufficiently active, sufficiently active); vitamin use (yes, no) and BMI (obese, overweight, normal). 
 
